Cephalon, Inc. And Takeda Pharmaceutical Co. Ltd. Announce Agreement To Co-Promote PROVIGIL(R) In The United States
FRAZER, Pa., and LINCOLNSHIRE, Ill., June 12 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH - News) and Takeda Pharmaceuticals North America, Inc. today announced that the companies have entered into an agreement to co- promote PROVIGIL® (modafinil) Tablets [C-IV] in the United States.